Bacaling, Rizzah .
HRN: 12-90-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
CEFUROXIME 500MG (TAB)
02/29/2024
03/07/2024
PO
500mg Tab
BID
CAP- LR, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes